Article info

Download PDFPDF

Original article
Ten-year outcome of enzyme replacement therapy with agalsidase beta in patients with Fabry disease

Authors

  1. Correspondence to Professor Dominique P Germain, Division of Medical Genetics, University of Versailles—St Quentin en Yvelines, Hopital Raymond Poincare (AP-HP), 92380 Garches, France; dominique.germain{at}rpc.aphp.fr
View Full Text

Citation

Germain DP, Charrow J, Desnick RJ, et al
Ten-year outcome of enzyme replacement therapy with agalsidase beta in patients with Fabry disease

Publication history

  • Received September 29, 2014
  • Revised January 31, 2015
  • Accepted February 11, 2015
  • First published March 20, 2015.
Online issue publication 
April 16, 2015

Article Versions

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

    Files in this Data Supplement:

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.